Literature DB >> 7279827

'Pulse' methylprednisolone and cyclophosphamide therapy in idiopathic rapidly progressive glomerulonephritis.

G Friedman, H Granot, Y Koplovic, M Friedlander.   

Abstract

The clinical report of a 31-year-old man who developed acute renal failure due to idiopathic rapidly progressive glomerulonephritis is presented. Intravenous pulse methylprednisolone therapy in combination with cyclophosphamide resulted in marked improvement in renal function. The literature dealing with pulse therapy is reviewed.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7279827      PMCID： PMC2424784          DOI： 10.1136/pgmj.57.663.54

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  11 in total

1.  The differential diagnosis of crescentic glomerulonephritis. The pathology of specific lesions with prognostic implications.

Authors:  B H Spargo; N G Ordóñez; J C Ringus
Journal:  Hum Pathol       Date:  1977-03       Impact factor: 3.466

2.  Letter: Cyclophosphamide in treatment of nephrotic syndrome.

Authors:  L S Ibels; A A Palmer; J F Mahony; J H Stewart
Journal:  Br Med J       Date:  1975-02-01

3.  "Pulse" methylprednisolone therapy in the treatment of severe glomerulonephritis.

Authors:  B R Cole; J T Brocklebank; R A Kienstra; J M Kissane; A M Robson
Journal:  J Pediatr       Date:  1976-02       Impact factor: 4.406

4.  Antiglomerular basement membrane antibody-mediated glomerulonephritis and Goodpasture's syndrome.

Authors:  W A Briggs; J P Johnson; S Teichman; H C Yeager; C B Wilson
Journal:  Medicine (Baltimore)       Date:  1979-09       Impact factor: 1.889

5.  Idiopathic crescentic glomerulonephritis.

Authors:  G J Beirne; J P Wagnild; S W Zimmerman; P D Macken; P M Burkholder
Journal:  Medicine (Baltimore)       Date:  1977-09       Impact factor: 1.889

6.  Intravenous pulse methylprednisolone therapy of acute crescentic rapidly progressive glomerulonephritis.

Authors:  W K Bolton; W G Couser
Journal:  Am J Med       Date:  1979-03       Impact factor: 4.965

7.  Reversal of acute clinical and experimental organ rejection using large doses of intravenous prednisolone.

Authors:  P R Bell; J D Briggs; K C Calman; A M Paton; R F Wood; S G Macpherson; K Kyle
Journal:  Lancet       Date:  1971-05-01       Impact factor: 79.321

8.  Cyclophosphamide therapy of severe systemic necrotizing vasculitis.

Authors:  A S Fauci; P Katz; B F Haynes; S M Wolff
Journal:  N Engl J Med       Date:  1979-08-02       Impact factor: 91.245

9.  High-dose corticosteroids: their use in treating idiopathic rapidly progressive glomerulonephritis.

Authors:  W M O'Neill; W B Etheridge; H A Bloomer
Journal:  Arch Intern Med       Date:  1979-05

10.  Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis.

Authors:  C M Lockwood; A J Pinching; P Sweny; A J Rees; B Pussell; J Uff; D K Peters
Journal:  Lancet       Date:  1977-01-08       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.